JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12
Abstract Breast cancer is the most common cancer worldwide. JWA is a microtubule-associated protein that has been identified as a tumor suppressor, and its downregulation in tumors is an independent adverse prognostic factor. The objective of this study was to explore the expression, regulation, and...
Main Authors: | Yan Liang, Chao Qian, Yinghong Xie, Xiang Huang, Junjie Chen, Yanlin Ren, Ziyi Fu, Yongfei Li, Tianyu Zeng, Fan Yang, Jianwei Zhou, Wei Li, Yongmei Yin, Changqing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-10-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-021-00693-9 |
Similar Items
-
JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
by: Yanlin Ren, et al.
Published: (2021-04-01) -
JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC
by: Zurong Zhai, et al.
Published: (2022-04-01) -
JWA inhibits nicotine-induced lung cancer stemness and progression through CHRNA5/AKT-mediated JWA/SP1/CD44 axis
by: Kun Ding, et al.
Published: (2023-07-01) -
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
by: Kun Ding, et al.
Published: (2022-09-01) -
Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer.
by: Xin Liu, et al.
Published: (2012-01-01)